Status:
RECRUITING
Pleural Carcinomatosis Tissue Banking
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Pleural Effusion, Malignant
Eligibility:
All Genders
18-110 years
Brief Summary
Malignant pleural effusion is a common evolution of various cancers and is associated with poor prognosis and quality of life. About 28% of patients with primary malignancy will develop pleural metast...
Eligibility Criteria
Inclusion
- Male or female over 18 years old
- Malignant pleural effusion with or without prior histological or cytological diagnosis
- Patient eligible for a pleural biopsy for diagnostic purposes and validated in a multidisciplinary consultation meeting
- Having given their free and informed writing consent
- Affiliated to a social security system or assimilated
Exclusion
- Malignant pleural mesothelioma
- Contraindication to general anesthesia
- Pregnant or breastfeeding woman, or is of child bearing potential and who did not agree to use highly effective methods of birth control throughout the study.
- Patient participating in a interventional study likely to interfere with this study
- Patient benefiting from a legal protection measure (guardianship or curatorship)
Key Trial Info
Start Date :
November 17 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 17 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04844827
Start Date
November 17 2022
End Date
November 17 2025
Last Update
November 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Louis Pradel Hospital
Bron, France, 69500